Lambertini Martina, Patrizi Annalisa, Peris Ketty, Marasco Giovanni, Toselli Marco, Marcelli Emanuela, Giampieri Enrico, Mussi Martina, Dika Emi
Division of Dermatology, IRCCS Policlinico di Sant'Orsola, Bologna, Italy, Division of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC di Dermatologia, Rome, Italy, Università Cattolica del Sacro Cuore, Dermatologia, Rome, Italy.
Eur J Dermatol. 2021 Feb 1;31(1):55-59. doi: 10.1684/ejd.2021.3970.
Since December 2019, the global population has been experiencing an unprecedented challenge due to Corona virus disease (COVID-19). A pandemic was declared by the World Health Organization on March 11 2020, with an escalation of new cases worldwide. Dermatology units experienced a reorganization of regular activity, also providing clinical diagnosis and medical assistance to COVID-19-positive patients who developed cutaneous manifestations.
To evaluate the impact of the COVID-19 pandemic on Italian dermatologic clinical practice.
MATERIALS & METHODS: This was a prospective online survey, consisting of a questionnaire with 35 multiple-choice questions uploaded on the website of the Italian Society of Dermatology and Venereology - SIDeMaST.
A total of 136 dermatologists, 78 women (57%) and 58 men (43%), participated in the survey. The mean age was 58 ± 14 years. In total, 60% of participants reported an impact of the pandemic on their practice, in most cases consisting of a remarkable reduction in routine clinical activity (58%). Concern regarding possible infection was evaluated with a score ranging from 0 (no concern) to 5 (extremely concerned): the fear of becoming infected was high (≥3 in 40%), as was the fear of infecting families, colleagues or patients (≥3 points in 45%).
The COVID-19 pandemic is having a strong impact on dermatology practice in Italy. The identification of critical points may help scientific societies to improve the clinical scenario and create specific strategies to overcome the emergency.
自2019年12月以来,全球人口因冠状病毒病(COVID-19)面临前所未有的挑战。2020年3月11日,世界卫生组织宣布该疾病为大流行病,全球新病例不断增加。皮肤科科室的常规活动进行了重新安排,同时也为出现皮肤表现的COVID-19阳性患者提供临床诊断和医疗援助。
评估COVID-19大流行对意大利皮肤科临床实践的影响。
这是一项前瞻性在线调查,通过在意大利皮肤病与性病学会(SIDeMaST)网站上发布的一份包含35个多项选择题的问卷进行。
共有136名皮肤科医生参与了调查,其中78名女性(57%),58名男性(43%)。平均年龄为58±14岁。总体而言,60%的参与者报告大流行对其临床实践产生了影响,在大多数情况下表现为常规临床活动显著减少(58%)。对可能感染的担忧程度用0分(无担忧)至5分(极度担忧)来评估:担心被感染的比例较高(40%的人得分≥3分),担心感染家人、同事或患者的比例也较高(45%的人得分≥3分)。
COVID-19大流行对意大利的皮肤科实践产生了重大影响。找出关键点可能有助于科学协会改善临床状况,并制定具体策略以应对这一紧急情况。